Cover Image
市場調查報告書

EpiCast Report:靜脈血栓閉塞症的流行病學的預測

EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2025

出版商 GlobalData 商品編碼 366912
出版日期 內容資訊 英文 69 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:靜脈血栓閉塞症的流行病學的預測 EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2025
出版日期: 2016年07月18日 內容資訊: 英文 69 Pages
簡介

本報告提供全球主要8個國家 (美國、法國、德國、義大利、西班牙、英國、日本、中國) 的靜脈血栓閉塞症的發病情形與今後預測相關分析,疾病的特徵和主要的併發症,目前患病人數與未來預測 (今後10年),相關市場 (膝關節、髖關節植入手術等)的趨勢預測等調查評估。

第1章 目錄

第2章 流行病學

  • 疾病的背景情況
  • 風險要素和共生病症
  • 全世界的趨勢
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法
  • 靜脈血栓閉塞症的流行病學的預測 (今後11年份)
    • 肺動脈栓塞
    • 深部靜脈血栓症
    • 靜脈血栓閉塞症 (VTE)
    • VTE的住院患者與風險患者的出院標準
    • 膝關節的完全植入治療數量 (初期/修正)
    • 髖關節置換手術的數量
  • 議論
    • 流行病學的預測相關考察
    • 分析的限制
    • 分析的優勢

第3章 附錄

圖表一覽

目錄
Product Code: GDHCER122-16

Venous thromboembolism (VTE), comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded flow of blood, which can have serious consequences in the affected individual. VTE can occur at any age, though it is more common in adults ages 60 years and older and is very rare in children. VTE events are highly dangerous and are associated with high rates of mortality and morbidity.

GlobalData epidemiologists forecast an increase in the diagnosed incident cases of VTE in the 8MM, from 1,116,358 cases in 2015 to 1,354,846 in 2025, at an Annual Growth Rate (AGR) of 2.14%. The 8MM had 314,886 diagnosed incident cases of Pulmonary Embolism (PE) in 2015 and GlobalData epidemiologists expect the diagnosed incident cases of PE to increase to 377,612 by 2025, at an AGR of 1.99%. GlobalData epidemiologists forecast an increase in the diagnosed incident cases of Deep Vein Thrombosis (DVT) in the 8MM to increase from 801,472 cases in 2015 to 977,234 cases by 2025, at an AGR of 2.19%. GlobalData epidemiologists also forecast the number of medically ill patients at risk for VTE to increase in the 8MM from 44,611,144 in 2015 to 54,143,874 in 2025. In addition, GlobalData epidemiologists forecast the number of total knee replacement and revision procedures to grow from 1,532,360 in 2015 to 1,867,289 in 2025. Furthermore, the number of hip replacements is forecast to grow 1,220,965 in 2015 to 1,512,215 in 2025. GlobalData epidemiologists have identified the predominant drivers of this market to be changes in country-specific incidence and procedure rates, as well as in the underlying demographic trends.

Scope

  • The Venous thromboembolism (VTE) EpiCast Report is an overview of the risk factors, comorbidities, and the global and historical trends for VTE in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China). It includes a 10-year epidemiological forecast for the diagnosed incident cases of PE, DVT, and VTE; the number of VTE attacks; the number of medically ill discharges that are at risk for VTE; the number of primary total knee replacements and revisions; and the number of hip replacements, each segmented by sex and age. Additionally, it includes a forecast for the number of recurrent VTE cases at one and 10 years after incident event, and the number of diagnosed VTE cases with cancer as comorbidity.
  • The VTE epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The VTE EpiCast report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global VTE market.
  • Quantify patient populations in the global VTE market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for VTE therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Epidemiology

  • 2.1. Disease Background
  • 2.2. Risk Factors and Comorbidities
  • 2.3. Global Trends
  • 2.4. Forecast Methodology
    • 2.4.1. Sources Used
    • 2.4.2. Forecast Assumptions and Methods
    • 2.4.3. Sources Not Used
  • 2.5. Epidemiological Forecast for VTE (2015-2025)
    • 2.5.1. Pulmonary Embolism
    • 2.5.2. Deep Vein Thrombosis
    • 2.5.3. VTE
    • 2.5.4. Number of Hospital Discharges Meeting Criteria for Medically Ill and Those at Risk for VTE
    • 2.5.5. Number of Primary Total Knee Replacements and Revisions
    • 2.5.6. Number of Hip Replacements
  • 2.6. Discussion
    • 2.6.1. Epidemiological Forecast Insight
    • 2.6.2. Limitations of the Analysis
    • 2.6.3. Strengths of the Analysis

3. Appendix

  • 3.1. Bibliography
  • 3.2. Physicians and Specialists Included in this Study
  • 3.3. About the Authors
    • 3.3.1. Epidemiologists
    • 3.3.2. Reviewers
    • 3.3.3. Global Director of Therapy Analysis and Epidemiology
    • 3.3.4. Global Head of Healthcare
  • 3.4. About GlobalData
  • 3.5. About EpiCast
  • 3.6. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for VTE
  • Table 2: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of PE
  • Table 3: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of DVT
  • Table 4: 8MM, Sources Used to Forecast the Number of Hospital Discharges that Meet the Criteria for Medically Ill
  • Table 5: 6MM, Sources Used to Forecast Primary Total Knee Replacements
  • Table 6: 6MM, Sources Used to Forecast the Rate of Primary Total Knee Replacement Requiring Revisions
  • Table 7: Japan and China, Sources Used to Forecast Primary Total Knee Replacements and Revisions
  • Table 8: 8MM, Sources Used to Forecast Hip Replacements
  • Table 9: 8MM, Diagnosed Incident Cases of PE, All Ages, Both Sexes, Select Years 2015-2025
  • Table 10: 8MM, Diagnosed Incident Cases of DVT, All Ages, Both Sexes, Select Years 2015-2025
  • Table 11: 8MM, Diagnosed Incident Cases of VTE, All Ages, Both Sexes, Select Years 2015-2025
  • Table 12: 8MM, Age-Specific Diagnosed Incident Cases of VTE, Both Sexes, N (Row %), 2015
  • Table 13: 8MM, Sex-Specific Diagnosed Incident Cases of VTE, Both Sexes, N (Row %), 2015
  • Table 14: 8MM, Number of Recurrent VTE Cases One and 10 Years After Incident VTE Event, Both Sexes, All Ages, N, 2015
  • Table 15: 8MM, Number of VTE Cases With Cancer Comorbidity, Both Sexes, All Ages, N, 2015 and 2025
  • Table 16: 8MM, Number of VTE Attacks, Both Sexes, All Ages, N, 2015-2025
  • Table 17: 8MM, Number of Hospital Discharges Meeting Criteria for Medically Ill; Those at risk for VTE, Both Sexes, Ages ≥40 Years, N, 2015
  • Table 18: 8MM, Number of Primary Total Knee Replacements and Revisions, Both Sexes, Ages ≥15 Years
  • Table 19: 8MM, Number of Hip Replacements, Both Sexes, Ages ≥15 Years

List of Figures

  • Figure 1: 8MM, Diagnosed Incident Cases of PE, All Ages, Both Sexes, Select Years 2015-2025
  • Figure 2: Age-Standardized Diagnosed Incidence of PE, All Ages, Cases Per 100,000, 2015
  • Figure 3: 8MM, Diagnosed Incident Cases of DVT, All Ages, Both Sexes, Select Years 2015-2025
  • Figure 4: Age-Standardized Diagnosed Incidence of DVT, All Ages, Cases Per 100,000 Population, 2015
  • Figure 5: 8MM, Diagnosed Incident Cases of VTE, All Ages, Both Sexes, Select Years 2015-2025
  • Figure 6: 8MM, Age-Specific Diagnosed Incident Cases of VTE, Both Sexes, N (Row %), 2015
  • Figure 7: 8MM, Sex-Specific Diagnosed Incident Cases of VTE, Both Sexes, N, 2015
  • Figure 8: 8MM, Number of VTE Attacks, Both Sexes, All Ages, N, 2015-2025
  • Figure 9: 8MM, Number of Primary Total Knee Replacements and Revisions, Both Sexes, Ages ≥15 Years
  • Figure 10: 8MM, Number Hip Replacements, Both Sexes, Ages ≥15 Years
Back to Top